Post by Novo Nordisk

We have just announced an investment of 432 million euro in our facility in Athlone, Ireland. This tabletting facility will provide significant additional manufacturing capacity for oral GLP-1s.   Learn more in the press release here: https://lnkd.in/eFFkr6HA